Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical Trial

PREVENT Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)484-494
Number of pages11
JournalOphthalmology Retina
Volume6
Issue number6
DOIs
StatePublished - Jun 2022

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • Anti-VEGF
  • Exudative age-related macular degeneration
  • Geographic atrophy
  • Intermediate age-related macular degeneration
  • Nonexudative age-related macular degeneration

Cite this